Tech Company Financing Transactions
Adlyfe Funding Round
On 1/18/2006, Adlyfe raised $3.3 million in Series A funding from Burrill & Company and Canaan Partners.
Transaction Overview
Company Name
Announced On
1/18/2006
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Series A
Investors
Burrill & Company (Ann Hanham)
Canaan Partners (Seth Rudnick)
Proceeds Purpose
With the financing, Adlyfe said that it has spun off its therapeutic business, which was based around technology freeze-drying platelets, into a new company called Cellphire Inc.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
9430 Key West Ave.
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Not Recorded
Overview
Adlyfe Inc. was established early in 2003 to develop novel technologies for blood testing for early targets of amyloid diseases. Adlyfe is developing a novel test for the detection and amplification of amyloid proteins as early biomarkers of fatal brain diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Cliff
Chief Scientific Officer
Robert Flower
Browse more venture capital transactions:
Prev: 1/18/2006: Advanced ICU Care venture capital transaction
Next: 1/18/2006: NanoGram venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs